中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (E)-N'-((2-(4-chlorophenoxy)quinolin-3-yl)methylene)-2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetohydrazide | 1594986-91-0 | C22H17ClN6O4 | 464.868 |
Substituted quinolines containing a 1,2,4-triazole moiety were synthesized using reported methods. The molecular docking studies support the experimental results that these compounds are active against
使用报道的方法合成了含有1,2,4-三唑基团的取代喹啉化合物。分子对接研究支持实验结果,表明这些化合物对
Prevention of α-amylase and β-glucosidase to reduce the postprandial blood sugar levels and delays dextrose absorption, the natural inhibitors provide an interesting approach to manage hyperglycemia with type 2 diabetes. The α-amylase and β-glucosidase are important therapeutic targets for type II diabetes. The isonicotinohydrazide phenoxy quinolines (5a-l) were synthesized and characterized by mass, 1H & 13C NMR. The characterized compounds are investigated for their in silico anti-hyperglycemic efficacy and the compounds shown effective to moderate inhibition against α-amylase and β-glucosidase enzymes. A molecular modelling study was performed for all the synthesized compounds to find the binding interaction of 5a-l with the α-amylase and β-glucosidase.